Recently, a case was settled with pharmaceutical manufacturer Pfizer Inc. on behalf of a family of a nine-year old girl who died as the result of the drug-induced disease, SJS that progressed to TEN, which caused all of her skin to slough off.
The victim died less than a month after receiving the Pfizer-produced drugs Dilantin® and Flagyl. Dilantin® is an anti-seizure drug and Flagyl is an anti-fungal. Shortly after the administration of the drugs, the patient developed a drug-induced condition known as TEN or toxic epidermal necrolysis. It causes a severe rash and skin sloughing, often followed by infections, blindness or death.
A study compiled by 15 burn centers in the U.S. revealed that more than 20% of TEN cases are believed to be caused by Dilantin® use, with deaths reported in approximately 1 of every 4 cases. Dilantin® is one of the most commonly prescribed anti-seizure drugs in the U.S.
First described in 1922, Stevens-Johnson Syndrome (SJS) is an immune-complex–mediated hypersensitivity complex that is a severe expression of erythema multiforme. It is known by some as erythema multiforme major, but disagreement exists in the literature.
Most authors and experts consider SJS and toxic epidermal necrolysis (TEN) different manifestations of the same disease.
For that reason, many refer to the entity as SJS/TEN. SJS typically involves the skin and the mucous membranes.
While minor presentations may occur, significant involvement of oral, nasal, eye, vaginal, urethral, GI, and lower respiratory tract mucous membranes may develop in the course of the illness. GI and respiratory involvement may progress to necrosis. SJS is a serious systemic disorder with the potential for severe morbidity and even death. Missed diagnosis is common.
Recent history of having taken a prescription or over-the-counter medication
Stevens Johnson Syndrome (SJS) is a rare skin disorder that can be caused by severe allergic reactions to pharmaceutical drugs that can potentially be fatal.
Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are very serious and potentially life-threatening conditions. These conditions can cause death or disable previously healthy people, although rare. SJS is a disease that quickly develops expanding rashes, and can create atypical target lesion, and involvement of the mucous membranes (mouth, eyes, and genital areas). Click here to fill out our online claim form and we will review your potential claim at no cost or obligation.
The FDA announced revisions to the labels of certain epilepsy, bipolar disorder and nerve pain medications to strengthen warnings about potential risk for rare skin disorders such as Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. The FDA has recommended that patients with Asian backgrounds undergo genetic tests before they take the treatments, the Wall Street Journal reports. The revisions apply to Carbamazepine (the active ingredient in Carbatrol, manufactured by Shire), Tegretol (manufactured by Novartis) and Equetro (manufactured by Validus Pharmaceuticals).
At the law offices of Peterson & Associates, P.C., our team of Dilantin® injury attorneys are dedicated to fighting for the rights of those that have suffered an injury due to taking the prescription drug Dilantin®.
If you or someone you love is a victim, contact us today by calling1-800-305-7552 or fill out our "Free Case Evaluation" form and we will contact you shortly after we receive your inquiry.